This work provides crucial insights into hypoxia-dependent stemness reprogramming and identifies a novel mechanism involving crosstalk between mitochondria and ER, encouraging the development of HIF-2α-targeting strategies for breast cancer patients, especially those who are resistant to chemotherapy. Here, EPAS1 is linked to breast carcinoma.